Current Opinion in Pulmonary Medicine

Papers
(The median citation count of Current Opinion in Pulmonary Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis72
Thoracic empyema: aetiology, diagnosis, treatment, and prevention42
The role of PET in the management of sarcoidosis29
The persistent problem of persistent air-leaks: approach to management28
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis27
Home monitoring in asthma: towards digital twins26
Bronchoscopic treatment of early-stage peripheral lung cancer25
Thoracic computed tomography in the progressive fibrotic phenotype22
The evolving role of radiological imaging in cystic fibrosis21
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease20
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis20
Digital outcome measures in pulmonary clinical trials18
Improving care in lung cancer surgery: a review of quality measures and evolving standards18
The different facets of sickle cell disease-related pulmonary hypertension18
The justification for the progressive fibrotic phenotype18
Bronchoscopic diagnosis of peripheral lung lesions17
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?17
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?17
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?17
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease17
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients16
Group 2 pulmonary hypertension: from diagnosis to treatment16
Implementation of digital home monitoring and management of respiratory disease14
Editorial introductions14
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity14
Editorial introductions14
Asthma in pregnancy: a review of recent literature14
Considerations and clinical management of infections in sarcoidosis13
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant13
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies13
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions13
The future of clinical trials in idiopathic pulmonary fibrosis12
Casting light on the many facets of sarcoidosis12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience12
Lung transplant referral considerations for individuals with cystic fibrosis12
The emerging role of inorganic elements as potential antigens in sarcoidosis12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes12
Progress for all: addressing disparities in sarcoidosis12
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens11
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing11
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis11
Tobacco treatment in the setting of lung cancer screening11
Cystic fibrosis liver disease in the post-modulator era11
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice11
Acute rejection post lung transplant11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease10
What causes cough in pulmonary fibrosis, and how should we treat it?10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease10
Imaging in peripheral bronchoscopy10
Home monitoring of coronavirus disease 2019 patients in different phases of disease10
Patterns of progression in non-IPF fibrotic interstitial lung disease9
Editorial: Are we ready for prime time?9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort9
Novel insights in fibrotic pulmonary sarcoidosis9
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators9
Exhaled breath analysis in interstitial lung disease9
Digital inhalers for asthma management9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease9
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective9
Effectiveness and safety of coronavirus disease 2019 vaccines9
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease8
The association of preexisting severe asthma with COVID-19 outcomes8
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease8
Altered pharmacology and toxicology during ageing: implications for lung disease8
Multidisciplinary care in nonmalignant central airway obstruction8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities8
Editorial: ‘What is your occupation?’: historical snippets8
Infection control in cystic fibrosis: evolving perspectives and challenges8
Epigenetics and aging: relevance for sleep medicine8
Telerehabilitation in pulmonary diseases8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future8
The changing landscape of infections in the lung transplant recipient7
Pulmonary rehabilitation in idiopathic pulmonary fibrosis7
Shifting gears: the search for group 3 pulmonary hypertension treatment7
Right ventricular assessment in pulmonary hypertension7
Adenotonsillectomy: the good, the bad and the unknown7
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps7
Telehealth and virtual health monitoring in cystic fibrosis7
Advancements in airway stents: a comprehensive update6
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice6
Updates in the diagnosis and management of chronic thromboembolic disease6
Prader–Willi syndrome: an update6
Long-term safety, durability of response, cessation and switching of biologics6
Military deployment-related respiratory problems: an update6
Editorial introductions6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?6
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?6
Ergonomics in bronchoscopy6
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?6
Editorial introductions6
Editorial introductions6
Approach to the hospitalized patient with pulmonary arterial hypertension6
COVID-19 outcomes in people with cystic fibrosis5
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?5
Pulmonary alveolar proteinosis – current and future therapeutical strategies5
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases5
Bacteriophages for bronchiectasis: treatment of the future?5
Drug-resistant tuberculosis: advances in diagnosis and management5
Methamphetamine-associated pulmonary arterial hypertension5
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer5
Interrelationships between tuberculosis and chronic obstructive pulmonary disease5
Bronchoscopic lung volume reduction in emphysema: a review5
Bronchoscopic interventions for chronic bronchitis5
Editorial introductions5
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis5
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach5
Recent advances predict a bright future for nebulizers5
Artificial intelligence for the optimal management of community-acquired pneumonia5
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice5
Editorial introductions5
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano5
Health inequities in the modulator era5
Indwelling pleural catheters for benign pleural effusions: a concise review4
Lung infections due to emerging fungal pathogens4
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine4
Risk stratification of pulmonary embolism4
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties4
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”4
Interstitial lung disease following coronavirus disease 20194
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea4
Anesthetic considerations in interventional pulmonology4
Environmental and occupational exposures in interstitial lung disease4
Editorial: The role of ageing in pulmonary disease4
Role of biomarkers in lung nodule evaluation4
What is new in mediastinal staging?4
Recent developments in occupational asthma4
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics4
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation4
Editorial introductions4
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide3
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension3
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes3
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 20213
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?3
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?3
The progressive fibrotic phenotype in current clinical practice3
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes3
Editorial introductions3
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment3
Whole lung lavage: considerations from the anesthesiology perspective3
Epidemiology of advanced cystic fibrosis lung disease in the modulator era3
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection3
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges3
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions3
Management of complicated parapneumonic effusions3
Editorial introduction3
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment3
Editorial introductions3
COVID-19: vaccines, efficacy and effects on variants3
Bedside to bench and back again-translational research in interventional pulmonology3
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 20193
Bronchodilator responsiveness in chronic obstructive pulmonary disease: prevalence, significance, and clinical implications2
Progress and challenges in fungal lung disease in cystic fibrosis2
Lung transplantation: practical and important directions of care2
Pulmonary adverse events following immune checkpoint inhibitors2
Glymphatic MRI techniques in sleep and neurodegenerative diseases2
Update in approaches to pulmonary hypertension because of left heart disease2
SMART - is it practical in the United States?2
Accuracy of respiratory event indices downloaded from positive airway pressure devices: can they be relied upon when making treatment decisions?2
Pediatric sarcoidosis with diagnostic and therapeutical insights2
Hit-hard and early versus step-up treatment in severe sarcoidosis2
Update on the genetic basis of obstructive sleep apnoea – hype or hope?2
Pregnancy and fertility in people with cystic fibrosis following lung transplantation2
Telehealth and its implementation in respiratory sleep medicine2
The controversy over daylight saving time: evidence for and against2
Vitamin D deficiency in chronic obstructive pulmonary disease2
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea2
Interstitial lung disease-associated pulmonary hypertension – what the future holds2
Ageing with Interstitial lung disease: preserving health and well being2
Detection of early phenotype cardiac sarcoidosis by cardiovascular magnetic resonance2
Editorial introductions2
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis2
Senescence in pulmonary arterial hypertension: is there a link?2
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic2
Editorial: The game is changing in sarcoidosis2
Sex differences in sleep and sleep-disordered breathing2
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice2
Chronic obstructive pulmonary disease and COVID-19: interrelationships2
Diversity and disparity in the treatment and care of sarcoidosis2
Leveraging AI technology in sarcoidosis2
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates2
Editorial introductions2
Treatment strategies for malignant pulmonary nodule: beyond lobectomy. Point-counterpoint2
Keeping global focus on the many challenges of respiratory tract infections2
0.060322046279907